Director/PDMR Shareholding

RNS Number : 2426E
Intl. Biotechnology Trust PLC
26 February 2020
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

The Company was notified today that Mrs Caroline Gulliver, a non-executive Director of the Company, purchased 2,500 Ordinary 25p shares in the capital of the Company on 26 February 2020 at a price of 592 pence per Ordinary share in London, which are registered in the name of CGWM Nominees Limited, representing 0.007% of the Company's issued share capital.

 

As a result of this purchase, Mrs Gulliver's aggregate holding of shares in the Company is 7,500 Ordinary shares, representing 0.020% of the Company's issued share capital.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Caroline Gulliver

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

International Biotechnology Trust plc

b)

LEI

213800N1QUJ744P76D11

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares

 

GB0004559349

b)

Nature of the transaction

Share purchase

c)

Price(s) and volume(s)

Price(s)

Volume(s)

592p

2,500

 

d)

Aggregated information

-

Aggregated volume


-

Price

 

N/A

 

 

N/A

e)

Date of the transaction

26 February 2020

f)

Place of the transaction

London Stock Exchange

 

Date of announcement: 26 FEBRUARY 2020


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBUGDDIBDDGGL
Investor Meets Company
UK 100